Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001568734-16-000003
Filing Date
2016-07-06
Accepted
2016-07-06 17:23:17
Documents
1
Period of Report
2016-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3202
  Complete submission text file 0001568734-16-000003.txt   4911
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET WORCESTER MA 01605
Business Address
SCHWARTZ MARK W. (Reporting) CIK: 0001422882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 161754683